Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of guaiacane-type sesquiterpene compound and its preparation method and application

A compound and composition technology, applied in the field of medicine, can solve problems such as potential safety hazards and unclear active ingredients, and achieve strong effects, anti-inflammatory effects, and inhibitory effects

Active Publication Date: 2022-02-08
JIANGSU KANION PHARMA CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, as a traditional Chinese medicine injection, its active ingredients for specific diseases are not clear, which also brings certain hidden dangers to safety.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of guaiacane-type sesquiterpene compound and its preparation method and application
  • A kind of guaiacane-type sesquiterpene compound and its preparation method and application
  • A kind of guaiacane-type sesquiterpene compound and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] The preparation of the compound of structure shown in embodiment 1 formula I

[0034] 1) 5,000 sticks of finished Reduning injection were dried under reduced pressure to obtain concentrated Reduning injection;

[0035] 2) Take the concentrated solution of step 1) and add purified water to dilute it, let it stand at room temperature, take the supernatant and separate it through a HP-20 macroporous adsorption resin column, elute with purified water of 4 times the column volume, and discard the eluent , carry out gradient elution with different concentrations of ethanol (10% ethanol, 30% ethanol, 50% ethanol, 70% ethanol, 95% ethanol, each eluent collects 4 column volumes), collects 95% ethanol elution site ;

[0036] 3) Take the 90% ethanol elution part of step 2), and separate through silica gel column (100-200 mesh silica gel) chromatography, and carry out gradient elution with dichloromethane-methanol as eluent (dichloromethane-methanol volume ratio respectively 1:0,...

Embodiment 2

[0049] The preparation of the compound of structure shown in embodiment 2 formula I

[0050] 1) 5,000 sticks of finished Reduning injection were dried under reduced pressure to obtain concentrated Reduning injection;

[0051] 2) Take the concentrated solution of step 1) and add purified water to dilute it, let it stand at room temperature, take the supernatant and separate it through a D101 macroporous adsorption resin column, elute with purified water of 3 times the column volume, discard the eluent, and use Carry out gradient elution with different concentrations of ethanol (5% ethanol, 25% ethanol, 45% ethanol, 65% ethanol, 90% ethanol, each eluent collects 3 column volumes), and collect the elution site of 90% ethanol;

[0052] 3) Take the 90% ethanol elution part of step 2), separate it through silica gel column (100-200 mesh silica gel) chromatography, and carry out gradient elution with dichloromethane-methanol as eluent (dichloromethane-methanol volume ratio respective...

Embodiment 3

[0056] Example 3 The compound of the structure shown in formula I resists PGE in vitro 2 experiment

[0057] 1. Materials

[0058] 1.1 Drug Compound shown in structural formula I;

[0059] 1.2 Cell model Mouse macrophage cell line RAW 264.7, from the Academy of Chinese Medical Sciences, provided by the entrusting party Jiangsu Kangyuan Pharmaceutical Co., Ltd.; culture conditions: DMEM+10% fetal bovine serum (FBS), 37 ° C, 5% CO 2 .

[0060] 2. Principles and methods

[0061] 2.1 Experimental principle

[0062] Lipopolysaccharide (LPS) of the outer membrane of Gram-negative bacteria (Sigma, USA, batch number: 114M4009) is one of the most important pathogenic molecules that mediate infectious inflammatory damage, and many diseases are closely related to the persistent subclinical inflammation induced by LPS. In animal and cell experiments, LPS is widely used to induce inflammation.

[0063]Macrophages play a vital role in the inflammatory response. After being stimulated,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a guaiac-type sesquiterpene compound and its preparation method and application. The compound having the structure shown in formula I described in the invention has relatively significant anti-inflammatory activity, and the preparation of the compound The method is simple in operation, strong in controllability and good in stability. .

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a guaiac-type sesquiterpene compound and a preparation method and application thereof. Background technique [0002] Inflammation is an important defense mechanism of the body against harmful stimuli, and the inflammatory response is the most basic anti-injury response of the body. Although it can promote wound healing and facilitate the capture of microorganisms, it can also cause a lot of damage, such as arthritis, asthma and body disorders, so anti-inflammatory drugs came into being. But today's anti-inflammatory drugs have many problems, such as causing stomach discomfort and increasing the risk of heart attack. Therefore, finding safe and effective anti-inflammatory drugs is still our unremitting goal. of which prostaglandin E 2 (prostaglandins E2, PGE 2 ) is an active substance involved in various physiological and pathological mechanisms such as inflammation and pain. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C49/733C07C45/78A61K31/122A61P29/00
CPCC07C49/733A61P29/00C07C2602/30
Inventor 肖伟李海波葛文邓奕杨彪刘文君曹亮胡晗绯王振中
Owner JIANGSU KANION PHARMA CO LTD